Patent / Jan 24, 2019
Preparation of amorphous form of vilanterol trifenatate for the treatment of asthma and chronic obstructive pulmonary disease
WO 2019016512 20190124
Oops! Your browser version is not supported by our website.
Please use these following browsers to view this page:
The New Jersey Department of Environmental Protection awarded Hovione New Jersey with the Environmental Stewardship
Drug Development & Delivery, June 2020
We partner, connect and align to shape supplier solutions that help Hovione reach its growth and objectives.
Hovione today announced the signing of a partnership agreement with Ligand to significantly ramp up the production output of Captisol®
Business Wire, September 23, 2020